Evaluation of Evidence for Pathogenicity Demonstrates That BLK , KLF11 , and PAX4 Should Not Be Included in Diagnostic Testing for MODY (2022)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.2337/db21-0844

PubMed Identifier: 35108381

Publication URI: http://europepmc.org/abstract/MED/35108381

Type: Journal Article/Review

Parent Publication: Diabetes

Issue: 5

ISSN: 0012-1797